Ovation Science Inc. (OVAT:CSE).

Sector

Cannabis

Commenced Trading

November 15 2018

Primary Exchange/Symbol

CSE:OVAT

Shares Issued, Outstanding

23,153,121

Investor Information

With over 30 years of entrepreneurial, business management and market initialization experience, Terry Howlett drives and directs Ovation Sciences’ development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation (he founded Skinvisible, Inc. in 1998), strategic planning and business growth; specializing in venture capital financing. You can contact Terry at 702.433.7154 or via email: terry@ovationscience.com

Nature Of The business

Ovation Science is an innovative drug development company with a high performance patented topical and transdermal delivery system called Invisicare® which enhances the delivery of cannabis and other ingredients to and through the skin.

Using pharmaceutical drug development protocols and innovation, Ovation Science has developed topical and transdermal cannabis product formulations; all delivered by Invisicare®. Our technology and formulations are licensed to national and international companies that are branding experts that manufacture and market these products globally.